Clayton Sleep Institute
St Louis, Missouri, 63123, United States
Location status: Recruiting
Location contact
Joseph Ojile, FCCP, D-ABSM
PRINCIPAL_INVESTIGATOR
Matthew Uhles
CONTACT
314-645-5855 ext. 318
Nicholas Bossaller
CONTACT
NCT Number: NCT07492420
The purpose of this study is to evaluate the safety and effectiveness of the MedCline Sleep System in reducing symptoms related to mild OSA.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
St Louis, Missouri, 63123, United States
Location status: Recruiting
Joseph Ojile, FCCP, D-ABSM
PRINCIPAL_INVESTIGATOR
Matthew Uhles
CONTACT
314-645-5855 ext. 318
Nicholas Bossaller
CONTACT
OSA is a common sleep disorder characterized by partial or complete obstruction of the upper airway during sleep that leads to intermittent pauses in breathing (apneas) or shallow breathing (hypopneas).
These interruptions can cause fragmented sleep, leading to daytime fatigue, cognitive impairments, and other health issues. Addressing mild OSA early is important, as it can progress to more severe forms if left untreated. OSA severity is measured using the Apnea-Hypopnea Index (AHI), which counts the number of apneas and hypopneas per hour of sleep. Estimates suggest that mild OSA, defined by an AHI of 5-14.9 events per hour, affects about 9-38% of adults with and increased prevalence in men and older adults. The Oxygen Desaturation Index (ODI) has been shown to be an alternative measure for OSA severity since AHI and ODI are heavily correlated and ODI is a valid predictor of OSA severity.
There are many treatment options available for patients with various severities of OSA. The gold standard for treating moderate or severe sleep apnea is Continuous Positive Airway Pressure (CPAP). CPAP therapy involves wearing a mask that provides a continuous flow of air to keep the airway open during sleep. However, some patients find CPAP uncomfortable or inconvenient, leading to patient compliance issues. Another option for patients with moderate or severe OSA is the use of intraoral devices. These devices reposition the lower jaw and tongue to keep the airway open. They require custom fitting by a dentist trained in sleep medicine. Access to these specialists, as well as concerns about discomfort and impact on teeth, can also limit their use as well as patient compliance.
For patients with mild OSA, positional therapy is a promising alternative. Positional therapy aims to prevent patients from sleeping in positions that exacerbate OSA, such as lying on their back (supine position), which has been demonstrated to worsen airway obstruction. Effective positional therapy should encourage side sleeping (lateral positioning) or elevating the head and shoulders, which can help reduce apneic events.
The American Academy of Sleep Medicine (AASM) "Practice Parameters for Medical Therapy of OSA" recommends positional therapy as an effective, non-invasive secondary treatment for mild OSA, especially when used alongside primary treatments like CPAP (AASM Guideline 3.5). FDA-authorized devices used for positional therapy include specialized pillows, belts, and electronic trainers that help maintain a side-sleeping or elevated position throughout the night. These devices are attractive solutions for patients for which CPAP may not be a practical first-line solution, such as patients with mild OSA.
The device that is the subject of this submission, the MedCline Sleep System, is a pillow-based positional therapy device based on the sleep positioning principles described above.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The MedCline Sleep System is an at-home positional therapy device to be placed on a bed surface.
Time frame: Night 1 to Night 8
Change in apneas per hour as measured by PSG (in-lab)
Time frame: Night 1 to Night 8
Change in oxygen desaturation per hour via PSG (in-lab)
Time frame: Night 1 to Night 8
Change in snoring during night
Contact information is provided by the study sponsor or research team.
Matthew Uhles
CONTACT
Nicholas Bossaller
CONTACT
Ph: (314) 353-9017
Amenity Health, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06587256
Apnea, Dyssomnias
Baltimore, Maryland, United States
View Trial DetailsNCT05087316
Mild Obstructive Sleep Apnea
Irbid, Others, Jordan
View Trial Details